Instrumental Wealth
VRTX icon

Instrumental Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Instrumental Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$233K Buy
446
+20
+5% +$10.2K 0.11% 80
2026
Q2 		$212K Buy
+426
New +$189K 0.11% 87

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Instrumental Wealth's VRTX Position: Q3 2026 in Review

Instrumental Wealth increased its Vertex Pharmaceuticals (VRTX) stake by 4.7% in Q3 2026, buying an estimated $10.2K and bringing the position to 446 shares worth $233K. The position accounts for 0.11% of the portfolio, ranked #80.

Instrumental Wealth first reported a position in VRTX in Q2 2026 and has held it in 2 quarters since. 386 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Instrumental Wealth held 446 shares of Vertex Pharmaceuticals worth $233K as of Q3 2026.
  • Instrumental Wealth bought 20 Vertex Pharmaceuticals shares in Q3 2026, an estimated $10.2K.
  • Vertex Pharmaceuticals made up 0.11% of Instrumental Wealth's portfolio in Q3 2026, its #80 holding.
  • Instrumental Wealth first reported a position in Vertex Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 386 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Instrumental Wealth's 13F filing for Q3 2026, filed 20 Oct 2026.